Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival

Transplant Immunology

Volumn 20, Issue 1-2, 2008, Pages 3-5

  Pretagostini, R ^a   Cinti, P ^a   Lai, Q ^a   Poli, L ^a   Berloco, P B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Immunosuppression; Kidney transplantation; Minimization; T suppressor cells

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DRUG DOSE REDUCTION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOLOGICAL MONITORING; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK; SUPPRESSOR CELL;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; CREATININE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY;

EID: 56049106095     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.08.008     Document Type: Article

References (11)

1. Meier-Kriesche H.U., Schold J.D., Srinivas T.R., and Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 4 (2004) 378-383
2. Shapiro R., Young J.B., Milford E.L., Trotter J.F., Bustami R.T., and Leichtman A.B. Immunosuppression: evolution in practice and trends, 1993-2003. Am. J. Transplant. 5 (2005) 874-886
3. Yang H. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance. Am J Kidney Dis. 47 4 Suppl 2 (Apr 2006) S37-51
4. Vanrenterghem Y., Van Hooff J.P., Squifflet J.P., Salmela K., Rigotti P., Jindal R.M., et al., European Tacrolimus/MMF Renal Transplantation Study Group. Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant. 5 1 (Jan 2005) 87-95
5. Augustine J.J., and Hricik D.E. Minimization of immunosuppression in kidney transplantation. Cur. Opin. Nefhrol. Hypertens. 16 6 (2007) 535-541
6. Rodrigo E., and Arias M. A practical approach to immune monitoring in kidney transplantation. Minerva Urol. Nefrol. 59 3 (2007) 337-352
7. Cortesini R., Renna-Molajoni E., Cinti P., Pretagostini R., Ho E., Rossi P., et al. Tailoring of immunosuppresion in renal and liver allograft recipients displaying donor specific T-suppressor cells. Hum. Immunol. 63 (2002) 1010-1012
8. Ashan N., Hricik D., Matas A., Rose S., Tomlanovich S., Wilkinson A., et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 68 (1999) 1865-1874
9. Vanrenterghem Y., Lebranchu Y., Hene R., Oppenheimer F., Ekberg H., and For the Steroid Dosing Study Group. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 70 (2000) 1352-1359
10. Abramowicz D., Manas D., Lao M., Vanrenterghem Y., Del Castillo D., Wijngaard P., et al., Cyclosporine Withdrawal Study Group. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study. Transplantation 74 (2002) 1725-1734
11. Suciu-Foca N., Manavalan J.S., and Cortesini R. Generation and function of antigen-specific suppressor and regulatory T cells. Transpl Immunol. 11 3-4 (Jul-Sep 2003) 235-244